NCT02449811View on ClinicalTrials.gov

RAS Peptide Profiles in Patients With Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

November 30, 2018

Conditions
Essential Hypertension
Interventions
DRUG

Perindopril

DRUG

Olmesartan

DRUG

Amlodipine

DRUG

Hydrochlorothiazide

Trial Locations (1)

4031

University Hospital, Basel

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02449811 - RAS Peptide Profiles in Patients With Arterial Hypertension | Biotech Hunter | Biotech Hunter